+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Facial Aesthetics Market By Product, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • PDF Icon

    Report

  • 279 Pages
  • July 2022
  • Region: Global
  • Allied Market Research
  • ID: 5671032
The global facial aesthetics market was valued at $6,234.5 million in 2021, and is projected to reach $25,764.5 million by 2031, registering a CAGR of 15.5% from 2022 to 2031. Facial aesthetics is a non-surgical procedure that revitalizes the skin. It is a facial rejuvenation treatment that reduces signs of ageing on the face. Facial aesthetic procedures provide more youthful and radiant appearance. The treatment offers facial contouring, defines certain facial features and it can soften wrinkles. Non-surgical aesthetic treatment helps in lifting up the confidence of people by improving the smile or skin in and masking the effect of age in less complicated way. Facial aesthetic procedure helps reduce and eliminate facial lines and wrinkles, it can treat scar and blemishes, it removes thicker and uneven skin layer and has many other benefits. In addition, non-surgical aesthetic procedures ensure quicker recovery and lesser pain than traditional surgical cosmetic procedures.

The facial aesthetics market is driven by rise in shift of customers toward minimally invasive and non-invasive procedures, increase in number of non-surgical aesthetic procedures such as facial contouring, Botox, injections, facial fillers and other, rise in awareness regarding skin health, and surge in expenditure on human healthcare services boosts growth of the market. According to a report by the American society of plastic surgeons (ASPS), in 2020, it was reported that around 16 million cosmetic procedures are conducted, globally. As per the same source, it was also reported that consumers spent approximately $20 billion on facial aesthetics procedures globally for total consumers. Moreover, according to a report shared by American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) in February 2022, total number of surgical and non-surgical procedures was 1.4 million in 2021, and have increased by 40% than 2020.

In addition, rise in number of botulinum toxin procedure which is also known as Botox injection anticipated to fuel the market growth. For instance, according to a report by Statista, published in 2021, botulinum toxin is the highest non-surgical procedure performed worldwide. Approximately 2.6 million botulinum toxin procedures were performed in 2020 across the globe. Moreover, rise in self-awareness among people regarding aesthetic appearance anticipated to propel the growth of facial aesthetics market. However, side effects associated with facial aesthetic procedures and high cost of procedures are anticipated to hinder the market growth during the forecast period. Side effects such as pain, swelling or bruising at injection site, skin rashes, skin infection hinder growth of the market. Development of products with advanced technologies for facial aesthetic procedures boost demand for facial aesthetics and provide growth opportunities for the facial aesthetics market. For instance, Galderma is a dermatology and pharmaceutical company, which received approval for two products. In May 2020, it received Food & Drug Administration (FDA) approval for restylane kysse, a new hyaluronic acid (ha) filler specifically designed and indicated to add fullness to lips and help smoothen wrinkles above the mouth.

The global facial aesthetics market is segmented on the basis of product, application, end user and region. The product segment is further classified into dermal fillers, botulinum toxin, microdermabrasion, chemical peels and others. On the basis of application, it is segmented into facial line correction treatment, scar treatment, lip enhancement, restoration of volume/ fullness and others.

On the basis end user, the market is categorized into specialty & dermatology clinics, hospitals and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global facial aesthetics market include AbbVie, Anika Therapeutics, Inc., Bausch Health Companies Inc., Candela Syneron, Cutera, Inc., Cynosure, Elan aesthetics, Evolus Inc., Fotona D.O.O, Galderma Laboratories, Ipsen, Johnson and Johnson, Merz Pharma, Revance Therapeutics, Sinclair Pharma, Teoxane, and Vital Esthetique.

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the facial aesthetics market analysis from 2021 to 2031 to identify the prevailing facial aesthetics market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the facial aesthetics market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global facial aesthetics market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Dermal fillers
  • Botulinum toxin
  • Microdermabrasion
  • Chemical peels
  • Others

By Application

  • Facial line correction treatment
  • Scar treatment
  • Lip enhancement
  • Restoration of volume or Fullness
  • Others

By End User

  • Specialty and Dermatology Clinics
  • Hospitals
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • 'Rest Of Europe '
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Rest Of Asia Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • Colombia
  • Rest of LAMEA

Key Market Players

  • Abbvie Inc
  • merz pharma
  • galderma laboratories, l.p.
  • Candela Syneron
  • Vital Esthetique
  • Teoxane
  • Johnson and Johnson
  • Cynosure
  • Bausch Health Companies Inc.
  • Sinclair Pharmaceuticals Limited
  • ipsen
  • Fotona D.O.O
  • Elan aesthetics
  • Anika Therapeutics, Inc.
  • Cutera, Inc.
  • Evolus Inc.
  • Revance Therapeutics

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: FACIAL AESTHETICS MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Dermal fillers
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Botulinum toxin
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Microdermabrasion
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Chemical peels
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Others
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
CHAPTER 5: FACIAL AESTHETICS MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Facial line correction treatment
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Scar treatment
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Lip enhancement
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Restoration of volume or Fullness
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
5.6 Others
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market analysis by country
CHAPTER 6: FACIAL AESTHETICS MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Specialty and Dermatology Clinics
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Hospitals
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: FACIAL AESTHETICS MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product
7.2.3 North America Market size and forecast, by Application
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Product
7.2.5.1.2 Market size and forecast, by Application
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product
7.2.5.2.2 Market size and forecast, by Application
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product
7.2.5.3.2 Market size and forecast, by Application
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product
7.3.3 Europe Market size and forecast, by Application
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product
7.3.5.1.2 Market size and forecast, by Application
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Product
7.3.5.2.2 Market size and forecast, by Application
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 U.K.
7.3.5.3.1 Market size and forecast, by Product
7.3.5.3.2 Market size and forecast, by Application
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Product
7.3.5.4.2 Market size and forecast, by Application
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Product
7.3.5.5.2 Market size and forecast, by Application
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 "Rest Of Europe "
7.3.5.6.1 Market size and forecast, by Product
7.3.5.6.2 Market size and forecast, by Application
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Product
7.4.5.1.2 Market size and forecast, by Application
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Product
7.4.5.2.2 Market size and forecast, by Application
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Product
7.4.5.3.2 Market size and forecast, by Application
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 Australia
7.4.5.4.1 Market size and forecast, by Product
7.4.5.4.2 Market size and forecast, by Application
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 Rest Of Asia Pacific
7.4.5.5.1 Market size and forecast, by Product
7.4.5.5.2 Market size and forecast, by Application
7.4.5.5.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product
7.5.3 LAMEA Market size and forecast, by Application
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product
7.5.5.1.2 Market size and forecast, by Application
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Product
7.5.5.2.2 Market size and forecast, by Application
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 Colombia
7.5.5.3.1 Market size and forecast, by Product
7.5.5.3.2 Market size and forecast, by Application
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Product
7.5.5.4.2 Market size and forecast, by Application
7.5.5.4.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Abbvie Inc
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 merz pharma
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 galderma laboratories, l.p.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Candela Syneron
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Vital Esthetique
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Teoxane
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Johnson and Johnson
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Cynosure
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Bausch Health Companies Inc.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Sinclair Pharmaceuticals Limited
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
9.11 ipsen
9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Operating business segments
9.11.4 Product portfolio
9.11.5 Business performance
9.11.6 Key strategic moves and developments
9.12 Fotona D.O.O
9.12.1 Company overview
9.12.2 Company snapshot
9.12.3 Operating business segments
9.12.4 Product portfolio
9.12.5 Business performance
9.12.6 Key strategic moves and developments
9.13 Elan aesthetics
9.13.1 Company overview
9.13.2 Company snapshot
9.13.3 Operating business segments
9.13.4 Product portfolio
9.13.5 Business performance
9.13.6 Key strategic moves and developments
9.14 Anika Therapeutics, Inc.
9.14.1 Company overview
9.14.2 Company snapshot
9.14.3 Operating business segments
9.14.4 Product portfolio
9.14.5 Business performance
9.14.6 Key strategic moves and developments
9.15 Cutera, Inc.
9.15.1 Company overview
9.15.2 Company snapshot
9.15.3 Operating business segments
9.15.4 Product portfolio
9.15.5 Business performance
9.15.6 Key strategic moves and developments
9.16 Evolus Inc.
9.16.1 Company overview
9.16.2 Company snapshot
9.16.3 Operating business segments
9.16.4 Product portfolio
9.16.5 Business performance
9.16.6 Key strategic moves and developments
9.17 Revance Therapeutics
9.17.1 Company overview
9.17.2 Company snapshot
9.17.3 Operating business segments
9.17.4 Product portfolio
9.17.5 Business performance
9.17.6 Key strategic moves and developments
List of Tables
Table 1. Global Facial Aesthetics Market, by Product, 2021-2031,($Million)
Table 2. Facial Aesthetics Market Revenue, for Dermal Fillers, by Region , 2021-2031,($Million)
Table 3. Facial Aesthetics Market for Dermal Fillers by Country, 2021-2031,($Million)
Table 4. Facial Aesthetics Market Revenue, for Botulinum Toxin, by Region , 2021-2031,($Million)
Table 5. Facial Aesthetics Market for Botulinum Toxin by Country, 2021-2031,($Million)
Table 6. Facial Aesthetics Market Revenue, for Microdermabrasion, by Region , 2021-2031,($Million)
Table 7. Facial Aesthetics Market for Microdermabrasion by Country, 2021-2031,($Million)
Table 8. Facial Aesthetics Market Revenue, for Chemical Peels, by Region , 2021-2031,($Million)
Table 9. Facial Aesthetics Market for Chemical Peels by Country, 2021-2031,($Million)
Table 10. Facial Aesthetics Market Revenue, for Others, by Region , 2021-2031,($Million)
Table 11. Facial Aesthetics Market for Others by Country, 2021-2031,($Million)
Table 12. Global Facial Aesthetics Market, by Application, 2021-2031,($Million)
Table 13. Facial Aesthetics Market Revenue, for Facial Line Correction Treatment, by Region , 2021-2031,($Million)
Table 14. Facial Aesthetics Market for Facial Line Correction Treatment by Country, 2021-2031,($Million)
Table 15. Facial Aesthetics Market Revenue, for Scar Treatment, by Region , 2021-2031,($Million)
Table 16. Facial Aesthetics Market for Scar Treatment by Country, 2021-2031,($Million)
Table 17. Facial Aesthetics Market Revenue, for Lip Enhancement, by Region , 2021-2031,($Million)
Table 18. Facial Aesthetics Market for Lip Enhancement by Country, 2021-2031,($Million)
Table 19. Facial Aesthetics Market Revenue, for Restoration of Volume or Fullness, by Region , 2021-2031,($Million)
Table 20. Facial Aesthetics Market for Restoration of Volume or Fullness by Country, 2021-2031,($Million)
Table 21. Facial Aesthetics Market Revenue, for Others, by Region , 2021-2031,($Million)
Table 22. Facial Aesthetics Market for Others by Country, 2021-2031,($Million)
Table 23. Global Facial Aesthetics Market, by End-user, 2021-2031,($Million)
Table 24. Facial Aesthetics Market Revenue, for Specialty and Dermatology Clinics, by Region , 2021-2031,($Million)
Table 25. Facial Aesthetics Market for Specialty and Dermatology Clinics by Country, 2021-2031,($Million)
Table 26. Facial Aesthetics Market Revenue, for Hospitals, by Region , 2021-2031,($Million)
Table 27. Facial Aesthetics Market for Hospitals by Country, 2021-2031,($Million)
Table 28. Facial Aesthetics Market Revenue, for Others, by Region , 2021-2031,($Million)
Table 29. Facial Aesthetics Market for Others by Country, 2021-2031,($Million)
Table 30. Facial Aesthetics Market, by Region, 2021-2031,($Million)
Table 31. North America Facial Aesthetics Market, by Product, 2021-2031,($Million)
Table 32. North America Facial Aesthetics Market, by Application, 2021-2031,($Million)
Table 33. North America Facial Aesthetics Market, by End-user, 2021-2031,($Million)
Table 34. North America Facial Aesthetics Market, by Country, 2021-2031,($Million)
Table 35. U.S. Facial Aesthetics Market, by Product, 2021-2031,($Million)
Table 36. U.S. Facial Aesthetics Market, by Application, 2021-2031,($Million)
Table 37. U.S. Facial Aesthetics Market, by End-user, 2021-2031,($Million)
Table 38. Canada Facial Aesthetics Market, by Product, 2021-2031,($Million)
Table 39. Canada Facial Aesthetics Market, by Application, 2021-2031,($Million)
Table 40. Canada Facial Aesthetics Market, by End-user, 2021-2031,($Million)
Table 41. Mexico Facial Aesthetics Market, by Product, 2021-2031,($Million)
Table 42. Mexico Facial Aesthetics Market, by Application, 2021-2031,($Million)
Table 43. Mexico Facial Aesthetics Market, by End-user, 2021-2031,($Million)
Table 44. Europe Facial Aesthetics Market, by Product, 2021-2031,($Million)
Table 45. Europe Facial Aesthetics Market, by Application, 2021-2031,($Million)
Table 46. Europe Facial Aesthetics Market, by End-user, 2021-2031,($Million)
Table 47. Europe Facial Aesthetics Market, by Country, 2021-2031,($Million)
Table 48. Germany Facial Aesthetics Market, by Product, 2021-2031,($Million)
Table 49. Germany Facial Aesthetics Market, by Application, 2021-2031,($Million)
Table 50. Germany Facial Aesthetics Market, by End-user, 2021-2031,($Million)
Table 51. France Facial Aesthetics Market, by Product, 2021-2031,($Million)
Table 52. France Facial Aesthetics Market, by Application, 2021-2031,($Million)
Table 53. France Facial Aesthetics Market, by End-user, 2021-2031,($Million)
Table 54. U.K. Facial Aesthetics Market, by Product, 2021-2031,($Million)
Table 55. U.K. Facial Aesthetics Market, by Application, 2021-2031,($Million)
Table 56. U.K. Facial Aesthetics Market, by End-user, 2021-2031,($Million)
Table 57. Italy Facial Aesthetics Market, by Product, 2021-2031,($Million)
Table 58. Italy Facial Aesthetics Market, by Application, 2021-2031,($Million)
Table 59. Italy Facial Aesthetics Market, by End-user, 2021-2031,($Million)
Table 60. Spain Facial Aesthetics Market, by Product, 2021-2031,($Million)
Table 61. Spain Facial Aesthetics Market, by Application, 2021-2031,($Million)
Table 62. Spain Facial Aesthetics Market, by End-user, 2021-2031,($Million)
Table 63. "Rest of Europe " Facial Aesthetics Market, by Product, 2021-2031,($Million)
Table 64. "Rest of Europe " Facial Aesthetics Market, by Application, 2021-2031,($Million)
Table 65. "Rest of Europe " Facial Aesthetics Market, by End-user, 2021-2031,($Million)
Table 66. Asia-Pacific Facial Aesthetics Market, by Product, 2021-2031,($Million)
Table 67. Asia-Pacific Facial Aesthetics Market, by Application, 2021-2031,($Million)
Table 68. Asia-Pacific Facial Aesthetics Market, by End-user, 2021-2031,($Million)
Table 69. Asia-Pacific Facial Aesthetics Market, by Country, 2021-2031,($Million)
Table 70. China Facial Aesthetics Market, by Product, 2021-2031,($Million)
Table 71. China Facial Aesthetics Market, by Application, 2021-2031,($Million)
Table 72. China Facial Aesthetics Market, by End-user, 2021-2031,($Million)
Table 73. Japan Facial Aesthetics Market, by Product, 2021-2031,($Million)
Table 74. Japan Facial Aesthetics Market, by Application, 2021-2031,($Million)
Table 75. Japan Facial Aesthetics Market, by End-user, 2021-2031,($Million)
Table 76. India Facial Aesthetics Market, by Product, 2021-2031,($Million)
Table 77. India Facial Aesthetics Market, by Application, 2021-2031,($Million)
Table 78. India Facial Aesthetics Market, by End-user, 2021-2031,($Million)
Table 79. Australia Facial Aesthetics Market, by Product, 2021-2031,($Million)
Table 80. Australia Facial Aesthetics Market, by Application, 2021-2031,($Million)
Table 81. Australia Facial Aesthetics Market, by End-user, 2021-2031,($Million)
Table 82. Rest of Asia-Pacific Facial Aesthetics Market, by Product, 2021-2031,($Million)
Table 83. Rest of Asia-Pacific Facial Aesthetics Market, by Application, 2021-2031,($Million)
Table 84. Rest of Asia-Pacific Facial Aesthetics Market, by End-user, 2021-2031,($Million)
Table 85. LAMEA Facial Aesthetics Market, by Product, 2021-2031,($Million)
Table 86. LAMEA Facial Aesthetics Market, by Application, 2021-2031,($Million)
Table 87. LAMEA Facial Aesthetics Market, by End-user, 2021-2031,($Million)
Table 88. LAMEA Facial Aesthetics Market, by Country, 2021-2031,($Million)
Table 89. Brazil Facial Aesthetics Market, by Product, 2021-2031,($Million)
Table 90. Brazil Facial Aesthetics Market, by Application, 2021-2031,($Million)
Table 91. Brazil Facial Aesthetics Market, by End-user, 2021-2031,($Million)
Table 92. Saudi Arabia Facial Aesthetics Market, by Product, 2021-2031,($Million)
Table 93. Saudi Arabia Facial Aesthetics Market, by Application, 2021-2031,($Million)
Table 94. Saudi Arabia Facial Aesthetics Market, by End-user, 2021-2031,($Million)
Table 95. Colombia Facial Aesthetics Market, by Product, 2021-2031,($Million)
Table 96. Colombia Facial Aesthetics Market, by Application, 2021-2031,($Million)
Table 97. Colombia Facial Aesthetics Market, by End-user, 2021-2031,($Million)
Table 98. Rest of LAMEA Facial Aesthetics Market, by Product, 2021-2031,($Million)
Table 99. Rest of LAMEA Facial Aesthetics Market, by Application, 2021-2031,($Million)
Table 100. Rest of LAMEA Facial Aesthetics Market, by End-user, 2021-2031,($Million)
Table 101. Abbvie Inc: Company Snapshot
Table 102. Abbvie Inc: Operating Segments
Table 103. Abbvie Inc: Product Portfolio
Table 104. Abbvie Inc: Net Sales
Table 105. Abbvie Inc: Key Stratergies
Table 106. Merz Pharma: Company Snapshot
Table 107. Merz Pharma: Operating Segments
Table 108. Merz Pharma: Product Portfolio
Table 109. Merz Pharma: Net Sales
Table 110. Merz Pharma: Key Stratergies
Table 111. Galderma Laboratories, L.P.: Company Snapshot
Table 112. Galderma Laboratories, L.P.: Operating Segments
Table 113. Galderma Laboratories, L.P.: Product Portfolio
Table 114. Galderma Laboratories, L.P.: Net Sales
Table 115. Galderma Laboratories, L.P.: Key Stratergies
Table 116. Candela Syneron: Company Snapshot
Table 117. Candela Syneron: Operating Segments
Table 118. Candela Syneron: Product Portfolio
Table 119. Candela Syneron: Net Sales
Table 120. Candela Syneron: Key Stratergies
Table 121. Vital Esthetique: Company Snapshot
Table 122. Vital Esthetique: Operating Segments
Table 123. Vital Esthetique: Product Portfolio
Table 124. Vital Esthetique: Net Sales
Table 125. Vital Esthetique: Key Stratergies
Table 126. Teoxane: Company Snapshot
Table 127. Teoxane: Operating Segments
Table 128. Teoxane: Product Portfolio
Table 129. Teoxane: Net Sales
Table 130. Teoxane: Key Stratergies
Table 131. Johnson and Johnson: Company Snapshot
Table 132. Johnson and Johnson: Operating Segments
Table 133. Johnson and Johnson: Product Portfolio
Table 134. Johnson and Johnson: Net Sales
Table 135. Johnson and Johnson: Key Stratergies
Table 136. Cynosure: Company Snapshot
Table 137. Cynosure: Operating Segments
Table 138. Cynosure: Product Portfolio
Table 139. Cynosure: Net Sales
Table 140. Cynosure: Key Stratergies
Table 141. Bausch Health Companies Inc.: Company Snapshot
Table 142. Bausch Health Companies Inc.: Operating Segments
Table 143. Bausch Health Companies Inc.: Product Portfolio
Table 144. Bausch Health Companies Inc.: Net Sales
Table 145. Bausch Health Companies Inc.: Key Stratergies
Table 146. Sinclair Pharmaceuticals Limited: Company Snapshot
Table 147. Sinclair Pharmaceuticals Limited: Operating Segments
Table 148. Sinclair Pharmaceuticals Limited: Product Portfolio
Table 149. Sinclair Pharmaceuticals Limited: Net Sales
Table 150. Sinclair Pharmaceuticals Limited: Key Stratergies
Table 151. Ipsen: Company Snapshot
Table 152. Ipsen: Operating Segments
Table 153. Ipsen: Product Portfolio
Table 154. Ipsen: Net Sales
Table 155. Ipsen: Key Stratergies
Table 156. Fotona D.O.O: Company Snapshot
Table 157. Fotona D.O.O: Operating Segments
Table 158. Fotona D.O.O: Product Portfolio
Table 159. Fotona D.O.O: Net Sales
Table 160. Fotona D.O.O: Key Stratergies
Table 161. Elan Aesthetics: Company Snapshot
Table 162. Elan Aesthetics: Operating Segments
Table 163. Elan Aesthetics: Product Portfolio
Table 164. Elan Aesthetics: Net Sales
Table 165. Elan Aesthetics: Key Stratergies
Table 166. Anika Therapeutics, Inc.: Company Snapshot
Table 167. Anika Therapeutics, Inc.: Operating Segments
Table 168. Anika Therapeutics, Inc.: Product Portfolio
Table 169. Anika Therapeutics, Inc.: Net Sales
Table 170. Anika Therapeutics, Inc.: Key Stratergies
Table 171. Cutera, Inc.: Company Snapshot
Table 172. Cutera, Inc.: Operating Segments
Table 173. Cutera, Inc.: Product Portfolio
Table 174. Cutera, Inc.: Net Sales
Table 175. Cutera, Inc.: Key Stratergies
Table 176. Evolus Inc.: Company Snapshot
Table 177. Evolus Inc.: Operating Segments
Table 178. Evolus Inc.: Product Portfolio
Table 179. Evolus Inc.: Net Sales
Table 180. Evolus Inc.: Key Stratergies
Table 181. Revance Therapeutics: Company Snapshot
Table 182. Revance Therapeutics: Operating Segments
Table 183. Revance Therapeutics: Product Portfolio
Table 184. Revance Therapeutics: Net Sales
Table 185. Revance Therapeutics: Key Stratergies
List of Figures
Figure 1. Facial Aesthetics Market Segmentation
Figure 2. Facial Aesthetics Market,2021-2031
Figure 3. Facial Aesthetics Market,2021-2031
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Facial Aesthetics Market:Drivers, Restraints and Opportunities
Figure 12. Facial Aesthetics Market,By Product,2021(%)
Figure 13. Comparative Share Analysis of Dermal Fillers Facial Aesthetics Market,2021-2031(%)
Figure 14. Comparative Share Analysis of Botulinum Toxin Facial Aesthetics Market,2021-2031(%)
Figure 15. Comparative Share Analysis of Microdermabrasion Facial Aesthetics Market,2021-2031(%)
Figure 16. Comparative Share Analysis of Chemical Peels Facial Aesthetics Market,2021-2031(%)
Figure 17. Comparative Share Analysis of Others Facial Aesthetics Market,2021-2031(%)
Figure 18. Facial Aesthetics Market,By Application,2021(%)
Figure 19. Comparative Share Analysis of Facial Line Correction Treatment Facial Aesthetics Market,2021-2031(%)
Figure 20. Comparative Share Analysis of Scar Treatment Facial Aesthetics Market,2021-2031(%)
Figure 21. Comparative Share Analysis of Lip Enhancement Facial Aesthetics Market,2021-2031(%)
Figure 22. Comparative Share Analysis of Restoration of Volume or Fullness Facial Aesthetics Market,2021-2031(%)
Figure 23. Comparative Share Analysis of Others Facial Aesthetics Market,2021-2031(%)
Figure 24. Facial Aesthetics Market,By End-user,2021(%)
Figure 25. Comparative Share Analysis of Specialty and Dermatology Clinics Facial Aesthetics Market,2021-2031(%)
Figure 26. Comparative Share Analysis of Hospitals Facial Aesthetics Market,2021-2031(%)
Figure 27. Comparative Share Analysis of Others Facial Aesthetics Market,2021-2031(%)
Figure 28. Facial Aesthetics Market by Region,2021
Figure 29. U.S. Facial Aesthetics Market,2021-2031($Million)
Figure 30. Canada Facial Aesthetics Market,2021-2031($Million)
Figure 31. Mexico Facial Aesthetics Market,2021-2031($Million)
Figure 32. Germany Facial Aesthetics Market,2021-2031($Million)
Figure 33. France Facial Aesthetics Market,2021-2031($Million)
Figure 34. U.K. Facial Aesthetics Market,2021-2031($Million)
Figure 35. Italy Facial Aesthetics Market,2021-2031($Million)
Figure 36. Spain Facial Aesthetics Market,2021-2031($Million)
Figure 37."Rest of Europe " Facial Aesthetics Market,2021-2031($Million)
Figure 38. China Facial Aesthetics Market,2021-2031($Million)
Figure 39. Japan Facial Aesthetics Market,2021-2031($Million)
Figure 40. India Facial Aesthetics Market,2021-2031($Million)
Figure 41. Australia Facial Aesthetics Market,2021-2031($Million)
Figure 42. Rest of Asia-Pacific Facial Aesthetics Market,2021-2031($Million)
Figure 43. Brazil Facial Aesthetics Market,2021-2031($Million)
Figure 44. Saudi Arabia Facial Aesthetics Market,2021-2031($Million)
Figure 45. Colombia Facial Aesthetics Market,2021-2031($Million)
Figure 46. Rest of LAMEA Facial Aesthetics Market,2021-2031($Million)
Figure 47. Top Winning Strategies, by Year
Figure 48. Top Winning Strategies, by Development
Figure 49. Top Winning Strategies, by Company
Figure 50. Product Mapping of Top 10 Players
Figure 51. Competitive Dashboard
Figure 52. Competitive Heatmap of Top 10 Key Players
Figure 53. Abbvie Inc.: Net Sales ,($Million)
Figure 54. Merz Pharma.: Net Sales ,($Million)
Figure 55. Galderma Laboratories, L.P..: Net Sales ,($Million)
Figure 56. Candela Syneron.: Net Sales ,($Million)
Figure 57. Vital Esthetique.: Net Sales ,($Million)
Figure 58. Teoxane.: Net Sales ,($Million)
Figure 59. Johnson and Johnson.: Net Sales ,($Million)
Figure 60. Cynosure.: Net Sales ,($Million)
Figure 61. Bausch Health Companies Inc..: Net Sales ,($Million)
Figure 62. Sinclair Pharmaceuticals Limited.: Net Sales ,($Million)
Figure 63. Ipsen.: Net Sales ,($Million)
Figure 64. Fotona D.O.O.: Net Sales ,($Million)
Figure 65. Elan Aesthetics.: Net Sales ,($Million)
Figure 66. Anika Therapeutics, Inc..: Net Sales ,($Million)
Figure 67. Cutera, Inc..: Net Sales ,($Million)
Figure 68. Evolus Inc..: Net Sales ,($Million)
Figure 69. Revance Therapeutics.: Net Sales ,($Million)

Executive Summary

According to the report, titled, “Facial Aesthetics Market," the facial aesthetics market size was valued at $6.23 billion in 2021, and is estimated to reach $25.76 billion by 2031, growing at a CAGR of 15.5% from 2022 to 2031. Facial aesthetics is a procedure where a person chooses non-invasive aesthetic treatment to change their physical appearance. It is performed for aesthetic purpose rather than medical reason. Facial aesthetics, also known as facial rejuvenation treatment which aims to revitalize the skin and provide youthful and radiant appearance.

There are various types of facial aesthetics procedures that women and men can choose to create an image that makes them feel more confident and comfortable with their appearance. There are different products available for facial aesthetics, such as cosmetic implants, chemical peels, dermal fillers, Botulinum toxin and microdermabrasion. The application of facial aesthetic treatment includes scar treatment, wrinkle reduction and face uplift, lip augmentation and facial line correction treatment. Laser skin resurfacing can reduce facial wrinkles, scars, and blemishes. Microdermabrasion treatments is a minimally invasive procedure used to renew overall skin tone and texture. In this treatment minimally abrasive instrument used to gently remove thicker, uneven outer layer, and has many benefits.

Factors that drive the growth of the facial aesthetics market trends include rise in geriatric population, increase in number of licensed medical centers to conduct facial aesthetic procedure, technological advancement in the medical aesthetic industry, and increase in the number of product launches by different key players. Moreover, acceptance and adoption of facial aesthetics is more in female population; therefore, increase in female population is anticipated to drive the facial aesthetics market growth.The non-invasive facial aesthetic procedures are highly popular among women due to increased levels of self-consciousness and a desire to be beautiful. For instance, according to a report shared by countrymeters, in 2022, global female population is 3,961,117,370. Moreover, according to data shared by woldometer, in 2022, the U.S. female population is 334,818,770.

Increase in number of approvals for aesthetic products boosts the market growth. For instance, in February 2022, Merz Aesthetics, a medical aesthetics company announced the launch of Radiesse (+) Lidocaine injectable implant for deep injection to improve moderate to severe loss of jawline contour in adults over the age of 21 years. Increase in number of licensed medical centers fuels the growth of facial aesthetics market. The reason behind increasing number of medical centers is attributed to increase in number of non-invasive procedures such as hydra-facial, laser toning, carbon laser peel, injectable skin boosters, chemical peel, dermal fillers and botox. Increase in skin damage and changes in lifestyle are the major factors that lead to rise in number of medical spas. Moreover, rise in self-awareness among young population regarding the physical appearance and increase in awareness regarding different facial aesthetic treatments among the female population are anticipated to propel the growth of facial aesthetics market.

The facial aesthetics market is segmented into product, application, end user and region.On the basis of product, the market is classified into dermal fillers, botulinum toxin, microdermabrasion, chemical peels and others. The dermal fillers segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to increase in adoption of dermal fillers by all age groups and rise in awareness about effectiveness of non-invasive aesthetic procedure among people.

On the basis of application, it is classified into facial line correction treatment, scar treatment, lip enhancement, restoration of volume/fullness and others. The facial line correction treatment segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to increase in geriatric population and rise in number of facial aesthetic procedure.

On the basis of end user, the market is classified into specialty & dermatology clinics, hospitals and others. The hospital segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to increase in number of hospitals and rise in expenditure by governments to improve the healthcare industry.  
North America accounted for a majority of the global facial aesthetics market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to rise in number of botulinum toxin procedures, increase in number of approvals for facial aesthetics products, presence of facial aesthetics industry, and advancements in medical and aesthetic sector in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to increase in geriatric populations, rise in awareness among young population regarding aesthetics, growth in healthcare expenditures, and rise in adoption of facial aesthetic products.

Key Findings of the Study

  • By product, the dermal fillers segment was the highest contributor to the market in 2021.
  • By application, the facial line correction treatment segment was the highest contributor to the market in 2021.
  • By end user, the hospital segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
  • By region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period

Companies Mentioned

  • Abbvie Inc
  • Merz Pharma
  • Galderma Laboratories, L.P.
  • Candela Syneron
  • Vital Esthetique
  • Teoxane
  • Johnson and Johnson
  • Cynosure
  • Bausch Health Companies Inc.
  • Sinclair Pharmaceuticals Limited
  • Ipsen
  • Fotona D.O.O
  • Elan Aesthetics
  • Anika Therapeutics, Inc.
  • Cutera, Inc.
  • Evolus Inc.
  • Revance Therapeutics

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information